YORVIPATH 420 micrograms/1.4 ml, solution for injection in a pre-filled pen 2 cartridges of 1.4 ml + 30 needles
Active ingredients: PALOPEGTÉRIPARATIDE, TÉRIPARATIDE
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection2 cartridges of 1.4 ml + 30 needlessous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- YORVIPATH 420 microgrammes/1,4 mL, solution injectable en stylo prérempli
- Pharmaceutical form
- solution injectable
- Route of administration
- sous-cutanée
- Presentation description
- 2 cartouches multidoses en verre de 1,4 mL dans 2 stylo pré-rempli + 30 aiguilles
- Marketing authorisation holder
- ASCENDIS PHARMA BONE DISEASES (DANEMARK)
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 15 Oct 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by specialists only
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
60401236CIP73028900CIP133400930289006Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TÉRIPARATIDEsolution | 420 microgrammes · un stylo prérempli | FT |
| PALOPEGTÉRIPARATIDEsolution | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.